A randomized controlled trial just published results that should change how we talk about app-based ADHD therapy.

337 adults with confirmed ADHD diagnoses. Three months. A digital CBT app called attexis matched face-to-face therapy on effect size. That’s not marketing copy. That’s what the data says: d=0.85, a –5.0 point drop on the ASRS (the standard ADHD symptom scale), versus the control group. Statistical significance at p<.001.

If you’ve ever wondered whether “therapy apps” are real treatment or just repackaged journaling, this trial gives you a concrete answer for the first time.

TL;DR for ADHD Brains

What	The Data
Sample	337 adults with confirmed ADHD
Duration	3 months
Primary result	–5.0 ASRS points vs. control (d=0.85, p<.001)
Secondary gains	Work/social functioning, self-esteem, reduced depression
Vs. in-person CBT	Comparable effect sizes. First digital ADHD therapy to show this.
App	attexis (CE-marked DiGA, Germany; available via app stores)

One-sentence verdict: This is the first digital ADHD therapy with head-to-head parity data against face-to-face CBT, and that matters enormously for access.

Best for: Adults with diagnosed ADHD who can’t access (or can’t afford) regular CBT sessions Worth knowing: This doesn’t replace a full treatment plan, but it’s no longer fair to call app-based CBT “just an app”

What Actually Got Measured

The Adult ADHD Self-Report Scale (ASRS) is the validated tool researchers use to track symptom severity over time. A –5.0 point swing in three months is meaningful. To give you a sense of scale: the clinical threshold for “significant improvement” in most ADHD medication trials is around 4–6 points on this scale.

The effect size of d=0.85 is large by psychological research standards. Cohen’s d of 0.8+ puts it in territory that clinicians usually associate with medium-to-high-efficacy medications, not apps.

But the primary outcome wasn’t the only thing that moved.

Secondary measures showed improvement across work and social functioning, self-esteem, quality of life, and depressive symptoms. These aren’t soft outcomes. People were sleeping better, performing better at work, and reporting less of the low-grade depression that tends to shadow unmanaged ADHD symptoms.

Why “Comparable to Face-to-Face CBT” Is a Big Deal

Most digital health research compares apps against waitlist controls (meaning people who aren’t getting any treatment). That’s a low bar. If your comparison group is “doing nothing,” almost any structured intervention looks effective.

This trial is different because the researchers compared attexis results against benchmark data from face-to-face CBT psychotherapy trials. The effect sizes landed in the same range.

That makes attexis (as far as the published evidence goes) the first digital ADHD therapy with actual parity data. Not “probably as good as therapy.” Not “may help with symptoms.” Head-to-head comparable outcomes.

This matters because the bar for calling something “evidence-based” in digital health has been embarrassingly low. A 2026 study in the Journal of Attention Disorders found that even apps with decent symptom outcomes often failed to improve real-world functioning. The attexis trial addressed both.

What CBT for ADHD Actually Does (And Why the App Version Can Work)

Standard CBT for depression is about catching negative thought patterns. CBT for ADHD is different. It targets the executive function breakdowns directly.

The core modules address task initiation (why you can’t start), time perception (why you’re always late), avoidance patterns (why you’d rather reorganize your sock drawer than open that email), and the shame spiral that accumulates when systems keep failing.

What makes digital CBT potentially viable for ADHD (not just “better than nothing”) is that the access barriers to face-to-face therapy are real. Most ADHD adults aren’t in CBT. The waitlists are months long, the copays add up, and attending weekly appointments is its own executive function challenge.

An app that delivers equivalent clinical outcomes from your couch, on your schedule, matters. A lot.

The Honest Part: What the Trial Doesn’t Tell You

I want to be straightforward about the limitations here, because this is the kind of research that gets turned into breathless headlines and then people feel ripped off when reality is more complicated.

This was a 3-month trial. We don’t have 12-month or 24-month data. Whether the gains hold without ongoing app use is unknown.

The control group wasn’t active treatment. Participants were measured against people not receiving structured ADHD support. They weren’t randomized against people actively in in-person CBT at the same time. The “parity with face-to-face CBT” claim is a comparison to historical benchmark data from other trials, which is common in this research design but is not the same as a direct head-to-head within the same study.

Self-report is self-report. The ASRS is validated and widely used, but symptom self-ratings have limits. Objective functioning measures (job performance, sustained attention tasks) were secondary outcomes, and those showed improvement too. That’s reassuring.

attexis is currently a CE-marked DiGA (Digitale Gesundheitsanwendung) in Germany. It’s available internationally through app stores, but its regulatory standing varies by country. U.S. readers: this is not FDA-cleared as a medical device, though that regulatory gap says more about FDA’s slow pace with digital therapeutics than about clinical evidence quality.

None of this undercuts the finding. It just means you should hold the results with appropriate confidence: “meaningfully promising, backed by real data” rather than “definitely works exactly as well as your therapist.”

How It Fits Into Your Existing Stack

This isn’t an either/or with other ADHD support tools.

If you’re already using productivity apps, AI coaching, or working on sleep and exercise, digital CBT addresses something different: the cognitive layer. Why you avoid tasks. What the internal monologue sounds like when initiation fails. How to interrupt the pattern before it cascades.

That’s not a job for your AI task manager or your body doubling app. Those accommodate the executive function gap. Digital or in-person, CBT is trying to close it slightly.

The stack I’d think about:

• If you’re in medication and it’s working but you’re still hitting walls: digital CBT is the most evidence-supported add-on for adults, per the BMJ umbrella review of ADHD interventions.
• If you’re managing without medication and looking for clinical-grade support: this trial suggests digital CBT is no longer a “better than nothing” recommendation. It has actual evidence behind it.
• If you’re already in face-to-face CBT: probably redundant for now. Different story if access becomes an issue.

For understanding how different ADHD presentations might respond differently, the ADHD evidence-based strategies guide covers the evidence hierarchy in full. The time blindness app roundup handles one of the specific symptoms CBT also targets.

Who This Is Most Likely to Help

The trial enrolled adults with confirmed ADHD diagnoses. Not suspected, not self-diagnosed. Confirmed. So the results most directly apply to people who’ve been through a clinical evaluation and know what they’re dealing with.

Within that group, digital CBT is most relevant for two situations. First: adults who’ve hit a ceiling with medication alone, or who can’t access regular CBT due to cost or waitlists. Second: anyone who’s been doing productivity systems for years without addressing the avoidance and shame patterns those systems are built around.

CBT for ADHD specifically isn’t about “being more positive.” It’s structured. It has protocols. The attexis app delivers those protocols with the same theoretical underpinnings you’d get from a trained therapist, just via software modules instead of a 50-minute session.

If your ADHD symptoms include significant emotional dysregulation or rejection sensitivity, that’s worth knowing going in. This trial measured core ADHD symptoms and functioning, not RSD specifically. The app may still help, but the evidence base for that particular dimension is thinner.

What to Actually Do With This Information

If you want to try attexis, it’s available on attexis.broca.io and through app stores. In Germany it’s covered by statutory health insurance as a DiGA. Outside Germany, pricing varies.

The app is built around guided CBT modules with psychotherapist-designed content. It’s not a chatbot, not an AI coach, and not a meditation app. It’s structured therapy delivered via software. That distinction matters for what you’re getting.

If you want to try it:

1. Download the app and complete the onboarding assessment honestly. (The tendency to present better than you’re doing is real. Don’t do it. It affects what modules you get.)
2. Commit to 10–15 minutes daily for the first three weeks. The trial protocol required consistent engagement. Sporadic use probably won’t replicate the results.
3. Track your ASRS score at baseline and at 30 days. The scale is freely available at chadd.org. Having a number to compare against tells you more than vibes.
4. If the modules feel too easy or too abstract, that’s data. Not every CBT delivery format works for every ADHD brain.

This trial doesn’t mean every ADHD app is suddenly credible. Most still aren’t. What it means is that the evidence base for this specific category (structured digital CBT with real clinical protocols) just got significantly stronger.

That’s worth paying attention to.

---

The attexis RCT enrolled 337 adults with confirmed ADHD diagnoses across a 3-month intervention period. Primary outcome: –5.0 ASRS points vs. control (Cohen’s d=0.85, p<.001). For the CHADD ASRS screener referenced above, visit chadd.org/for-adults/getting-an-adhd-diagnosis/.